ASPiRATION An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients Challenge Lung cancer is the leading cause of cancer death in Australia and worldwide, with a five-year survival rate of only 17 per cent. Study The ASPiRATION program is a pioneering partnership between government, industry and […]
Thoracic Oncology Group Of Australasia © 2020 All rights reserved
Thoracic Oncology Group of Australasia Ltd is a registered Income Tax Exempt Charity: Charitable Fundraising Authority ABN 47 641 984 198.
All donations over $2 are tax deductible.
Thoracic Oncology Group of Australasia Ltd. acknowledges the Traditional Custodians of the land on which we live and work. We pay our respect to their elders past, present and emerging. We also extend that respect to all Aboriginal people.